Pharmaresources: Announcement of Shanghai Hongbo Zhigen Pharmaceutical Co., Ltd.'s acquisition of investment fund shares and external investment
Pharmaresources: Announcement regarding the progress of repurchasing company shares.
Pharmaresources: Announcement on the Completion of Closure of Some Raised Funds Special Accounts
Pharmaresources: Announcement regarding the completion of industrial and commercial change registration and issuance of business license.
Pharmaresources: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
Pharmaresources: Legal opinion from Jia Yuan Law Firm in Beijing regarding the second interim shareholder meeting of Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. in 2024.
Pharmaresources: Announcement regarding the addition of proposals and supplementary notice for the second extraordinary shareholders' meeting in 2024.
Pharmaresources: Announcement on the progress of share repurchase where the proportion of the company's share repurchase has reached 1%.
Pharmaresources: Announcement of Notice about Shareholders Holding More Than 5% of Shares Reducing to Less Than 5% and Changes in Equity
Pharmaresources: Simplified Equity Change Report
Pharmaresources: Notice of the Second Extraordinary Shareholders' Meeting in 2024
Pharmaresources: Announcement regarding changes to the registered capital of the company, amendment of the company's articles of association, and filing of industrial and commercial change registration.
Pharmaresources: Announcement of the resolutions of the 17th meeting of the 3rd Board of Directors.
Pharmaresources: Revision of the Articles of Association of Shanghai Hongbo Zhigen Pharmaceutical Co., Ltd.
Pharmaresources: Simplified Equity Change Report
Pharmaresources: Announcement on the passive reaching of 5% shareholder holdings ratio and equity changes.
Pharmaresources: Announcement on adjusting the upper limit of share repurchase price after implementation of annual equity distribution in 2023.
Pharmaresources: Announcement of Annual Equity Distribution Implementation in 2023
Pharmaresources: Announcement on the progress of repurchasing the company's shares to reach 1% of the proportion.
Pharmaresources: Announcement on the lifting of the shareholder's equity pledge.
No Data